WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced it has entered into an agreement to acquire ...

WILMINGTON, N.C.–(BUSINESS WIRE)–Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced the completion of its acquisition of Evidera, a ...

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced the completion of its acquisition of Evidera, a ...

Pharmaceutical Product Development, LLC (PPD) has announced it has entered into an agreement to acquire Evidera to demonstrate the real-world effectiveness and value of biopharmaceutical products. The ...

PPD has put its medical affairs research operations (MARO) team under Evidera, the real-world research-focused subsidiary PPD bought last year. The new unit, with Evidera’s name, will still be ...

PPD has completed its buyout of research-based consulting company Evidera in what the CRO describes as “uniting two best-in-class research companies,” and boosting its services to its life science ...

Evidera, of Bethesda, Md., provides health economics, outcomes research, market access, data analytics and epidemiology services to life sciences organizations to help them gauge the effectiveness and ...

Evidera will become a wholly owned subsidiary of PPD, delivering peri- and post-approval studies, health economics, outcomes research, epidemiology and market access consulting. Leveraging PPD’s ...